ArticleMolecular pharmaceutics2025
Development of a Novel Engineered Antibody Format for PSMA-Targeted Radionuclide Therapy.
Nicholas L Fletcher et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it